Asian Spectator


The Times

.

LANDMARK’s ‘Destination CENTRAL’ Opens an Inspiring New Chapter for the Festive Season in Hong Kong

Heightening the Global Momentum of Louis Vuitton’s Monumental Façade and Welcoming the Arrival of “Christmas at The Gloucester Hotel”HONG KONG SAR – Media OutReach News...

Orange Premieres Deep Sleep Mode with SoftAtHome in New Wi-Fi ...

PARIS, April 8, 2022, /PRNewswire-AsiaNet/-- One of the first Wi-Fi 6E Operator boxes in the world, the new Livebox 6 is eco-responsible and offers the latest digital home services with the ...

SOMALIA OPEN FOR BUSINESS AS PRESIDENT THROWS HIS SUPPORT AT M...

HOUSTON, Oct. 21, 2022, /PRNewswire-AsiaNet/-- Federal Government of Somalia approves Coastline's Production Sharing AgreementsPresident of Somalia supports Coastline's Production Sharing Ag...

Supermicro Boosts Performance Up to 20x on Data Science, HPC a...

FRANKFURT, Germany, June 22, 2020/PRNewswire-AsiaNet/-- -- New Supermicro Servers with PCIe Gen 4 Feature Fully Optimized Support for the New NVIDIA A100 GPUs, Third Generation NVIDIA NVLink...

Risen Energy Brings Latest 210mm-based Rooftop Solar Module to...

NINGBO, China, May 20, 2022 /PRNewswire-AsiaNet/ -- Risen Energy ("the Company"), a leading solar module manufacturer in China, participated in Intersolar Europe 2022 where its whole suite o...

10th Edition of Singapore Media Festival to Spotlight Innovative Technologies, New Media Skills, and Creators’ Content

Festival-goers can celebrate the past and experience the future of Asia’s media industry’s best, with 11 days of screenings, showcase pavilions, discussion panels, fan meets, and...

Vinhomes advances urban development platform amid global shift toward nature-positive investment

HANOI, VIETNAM - Media OutReach Newswire - 7 August 2026 - As global institutional capital increasingly redefines value creation in real estate, Vinhomes, Vietnam's largest listed real esta...

Harbin Completes the World's Largest Indoor Ice and Snow Theme Park

HARBIN, CHINA - Media OutReach Newswire - 16 July 2024 - Recently, the Harbin Ice and Snow World's all-season ice and snow project has been fully operational. One of the key venues of the p...

Jacobson Pharma Issues Positive Profit Alert

Expects to Record Over 20% Increase in Profit Attributable to ShareholdersHONG KONG, May 2, 2019 - (ACN Newswire) - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company";...

Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity

Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity

SYDNEY, Apr 8, 2020 - (ACN Newswire) - Asia-Pacific's largest specialist biotech CRO Novotech said the top 10 biotech sites in Australia were open for clinical trial activity with many sites modifying their practices to ensure continuity of operations.

Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity

View and Download the COVID-19 Australia Data Bulletin here. https://novotech-cro.com/covid-19-notice

The data is part of a new series prepared for Novotech clients detailing the current status of trials in the Asia-Pacific during the global COVID-19 crisis.

Novotech CEO Dr John Moller said the Bulletin series taps local knowledge of fundamentals in the sector and shows which countries in the region are able to support clinical research for Novotech and its clients during this time.

"While the situation is always evolving, Australia appears to be managing the crisis well. Our sites have changed how they manage trials in line with Australian Government health guidelines and most are still able to deliver the clinical trial services we need for our clients," said Dr Moller. "Study delays caused by COVID-19 can be rapidly addressed by activating new sites in Australia and Asia."

Australia has attractive start-up times, world leading investigators and research teams, and valuable rebates of up to 43.5% on clinical trial spend.

About Novotech

Novotech, established in 1996, is internationally recognized as the leading full-service contract research organization (CRO) in Asia-Pacific. Novotech provides clinical development services across all clinical trial phases and therapeutic areas and has been instrumental in the success of over a thousand Phase I - IV clinical trials for biotech companies.

Novotech obtained the ISO 27001, the best-known standard in the ISO family, providing the requirements for an Information Security Management System. Together with the ISO 9001 Quality Management system, Novotech aims at the highest IT security and quality standards for patients and biotechnology companies. Visit http://novotech-cro.com.

For RFP enquiries: Please fill out the form available at https://novotech-cro.com/talk-to-an-expert

Media ContactSusan Fitzpatrick-Napiercommunications@novotech-cro.comAU: +61 2 8218 2144 USA: +1 415 951 3228Asia: +65 3159 3427

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

What to Consider Before Choosing a Cardboard Box Manufacturer

Start With the Packaging Purpose The right packaging begins with a clear understanding of what the box needs to do. A cardboard box manufacturer can help translate requirements such as product prot...

Why Emotional Battles Drain Your Wealth During Separation

Navigating a marriage ending is fundamentally a structural transition, not just an emotional event. When you approach separation with a clear roadmap, you protect your long term financial stability ...

How Long Does Botox Really Last? A Realistic Timeline

Someone might notice a line between their eyebrows getting deeper after a stressful week, or catch their forehead creasing in a video call in a way it did not before. It is a small observation, easy...

hacklink esim senegalzlibraryzlibraryuk casinos not on gamstophttps://www.capitolcitycinema.org/grandpashabet girişStreamEastCrackStreamsjojobetcialis 20 mg fiyathttps://elektroniksigarakeyfi.net/marka/voopoo/